Amikacin

Active ingredient description

Amikacin is an antibiotic used for a number of bacterial infections. Amikacin works by blocking the function of the bacteria’s 30S ribosomal subunit, making it unable to produce proteins.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
D06AX12
Amikacin
D Dermatologicals → D06 Antibiotics and chemotherapeutics for dermatological use → D06A Antibiotics for topical use → D06AX Other antibiotics for topical use
Discover more medicines within D06AX12
J01GB06
Amikacin
J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01G Aminoglycoside antibacterials → J01GB Other aminoglycosides
Discover more medicines within J01GB06
S01AA21
Amikacin
S Sensory organs → S01 Ophthalmologicals → S01A Antiinfectives → S01AA Antibiotics
Discover more medicines within S01AA21

Medicines

Amikacin is the active ingredient of these drugs:

Drug
Countries
AMICILON

Brazil

AMIKA-SYNTO

Cyprus

AMIKACIN

Austria

AMIKIN

Hong Kong United Kingdom

AMIWOK

Hong Kong

ARIKAYCE

Austria Finland Ireland Lithuania Netherlands

BIODACYNA

Lithuania Poland

CHEMACIN

Italy

LIKACIN

Hong Kong Italy

LUKADIN

Italy

MIACIN

Tunisia

MIKAN

Italy

NEKACIN

Italy

ORLOBIN

Hong Kong

SELEMYCIN

Cyprus Hong Kong

Product monographs

Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
AMIKIN INJECTION Solution for injection
Summary of Product Characteristics (SPC)
UK
ARIKAYCE Inhalation suspension
Structured Product Labeling (SPL/PLR)
US

Structural formula

Graphic representation of the active ingredient's molecular structure

Unique ingredient identifier (UNII)

84319SGC3C - AMIKACIN

CAS registry number

37517-28-5 - amikacin

39831-55-5 - Amikacin sulphate

SNOMED-CT

387266001 - Amikacin (substance)

Next: Usage